nach oben

Cancer and Metastasis Reviews

Erschienen in:

01.12.2013 | NON-THEMATIC REVIEW

Role of the host stroma in cancer and its therapeutic significance

verfasst von: David Tarin

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 3-4/2013

Einloggen, um Zugang zu erhalten

Abstract

Current cancer research focuses mainly upon the cancer cells in malignant tumours and is providing a growing database about aberrations in their genetic composition. However, tumours also contain non-cancerous host tissue, referred to as the stroma, which plays an active and indispensable role in tumour growth and influences the virulence of the neoplasm towards the host. Many cell types inhabit the stroma, amidst apparently inert fibrous and viscous matrix material, composed of complex polysaccharides, proteins and other molecules. Actually, all of these elements are in constant turnover, causing unpredictable evolution in the properties of the community. This article provides pathologic observations and data on reciprocal interactions between these stromal and neoplastic components of tumours and how they change during the course of the disease. Malignant progression depends upon dauntingly intricate communications between different specialised lineages within the cellular society, which enable rapid adaptation to changing circumstances. Opportunistic misuse of such communication networks enables tumour cells to recruit and incorporate adjacent normal stroma into their midst, so that they may grow, infiltrate and parasitise the host. The absolute dependency of primary tumours and metastases on their diverse stromal components for survival and their insatiable need to continuously recruit more stroma to support expansion, renders them vulnerable to strategies capable of disrupting the cellular interactions involved. This dependency is of critical importance for cancer therapy research, and proposed methods for turning this parasitic behaviour of tumours against themselves are suggested below.

Folkman, J. (2006). Angiogenesis. Annual Review of Medicine, 57, 1–18.PubMed

Yamagiwa, K., Ichikawa, K., cited by Yamagiwa KaI, K. (1918). Experimental study of the pathogenesis of carcinoma. Journal of Cancer Research 3, 1–29.

Orr, J. W. (1938). The changes antecedent to tumour formation during the treatment of mouse skin with carcinogenic hydrocarbons. Journal of Pathology and Bacteriology, 46, 495–515.

Billingham, R. E., Orr, J. W., & Woodhouse, D. L. (1951). Transplantation od skin components during chemical carcinogenesis with 20-methylcholanthrene. British Journal of Cancer, 5, 417–432.PubMed

Marchant, J., & Orr, J. W. (1953). Further attempts to analyse the role of epidermis and deeper tissues in experimental chemical carcinogenesis by transplantation and other method. British Journal of Cancer, 7, 329–341.PubMed

Orr, J. W., & Spencer, A. T. (1972). Transplantation studies of the role of the stroma in epidermal carcinogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 291–303). London: Academic.

Tarin, D. (2012). Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance. Cancer Metastasis Reviews, 31, 21–39.PubMed

Pelosof, L. C., & Gerber, D. E. (2010). Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clinic Proceedings Mayo Clinic, 85, 838–854.PubMed

Darnell, R., & Posner, J. (2011). Paraneoplastic syndromes. Oxford: Oxford University Press.

10.

Spemann, H. (1938). Embryonic development and induction. New Haven: Yale University Press.

11.

Grobstein, C. (1967). Mechanisms of organogenetic tissue interaction. National Cancer Institute Monograph, 26, 279–299.PubMed

12.

Saxén, L. (1972). Interactive mechanisms in morphogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 49–80). London: Academic.

13.

Kratchwil, K. (2001). Epithelial mesenchymal interactions. http://onlinelibrarywileycom/doi/101038/npgels0001141/full. Accessed 12 April 2013

14.

Franks, T. J., Colby, T. V., Travis, W. D., et al. (2008). Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proceedings of the American Thoracic Society, 5, 763–766.PubMed

15.

Beers, M. F., & Morrisey, E. E. (2011). The three R’s of lung health and disease: repair, remodeling, and regeneration. The Journal of Clinical Investigation, 121, 2065–2073.PubMed

16.

Cardoso, W. V., & Lu, J. (2006). Regulation of early lung morphogenesis: questions, facts and controversies. Development, 133, 1611–1624.PubMed

17.

Cardoso, W. V., & Whitsett, J. A. (2008). Resident cellular components of the lung: developmental aspects. Proceedings of the American Thoracic Society, 5, 767–771.PubMed

18.

Grobstein, C. (1953). Morphogenetic interaction between embryonic mouse tissues separated by a membrane filter. Nature, 172, 869–870.PubMed

19.

Kratochwil, K. (1972). Tissue interaction during embryonic development. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 1–47). London: Academic.

20.

Millar, S. E. (2002). Molecular mechanisms regulating hair follicle development. The Journal of Investigative Dermatology, 118, 216–225.PubMed

21.

Zorn, A.M. (2008). Liver development. In StemBook. Cambridge, MA. http://www.ncbi.nlm.nih.gov/books/NBK27068/pdf/Liver_development.pdf. Accessed 12 April 2013

22.

Landsman, L., Nijagal, A., Whitchurch, T. J., et al. (2011). Pancreatic mesenchyme regulates epithelial organogenesis throughout development. PLoS Biology, 9, e1001143.PubMed

23.

Tabin, C., & Wolpert, L. (2007). Rethinking the proximodistal axis of the vertebrate limb in the molecular era. Genes & Development, 21, 1433–1442.

24.

Hölldobler, B., & Wilson, E. (2008). The superorganism: the beauty, elegance, and strangeness of insect societies. New York: W.W. Norton Inc.

25.

Corning, P. (2002). The re-emergence of emergence: a venerable concept in search of a theory. Complexity, 7, 18–30.

26.

Arp, R. (2008). Life and the homeostatic organization view of biological phenomena. Cosmos and History: The Journal of Natural and Social Philosophy, 4, 260–282.

27.

Tarin, D. (2011). Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Seminars in Cancer Biology, 21, 72–82.PubMed

28.

Meilhac, S. M., Adams, R. J., Morris, S. A., et al. (2009). Active cell movements coupled to positional induction are involved in lineage segregation in the mouse blastocyst. Developmental Biology, 331, 210–221.PubMed

29.

Rinn, J. L., Bondre, C., Gladstone, H. B., et al. (2006). Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genetics, 2, e119.PubMed

30.

Shannon, J. M., & Hyatt, B. A. (2004). Epithelial–mesenchymal interactions in the developing lung. Annual Review of Physiology, 66, 625–645.PubMed

31.

Billingham, R. E., & Silvers, W. K. (1963). The origin and conservation of epidermal specificities. The New England Journal of Medicine, 268, 539–545. concl.PubMed

32.

Billingham, R., & Silvers, W. (1968). Dermoepidermal interactions and epithelial specificity. In R. Fleischmajer & R. Billingham (Eds.), Epithelial–mesenchymal interactions (pp. 252–266). Baltimore: Williams and Wilkins.

33.

Cunha, G. R., Fujii, H., Neubauer, B. L., et al. (1983). Epithelial–mesenchymal interactions in prostatic development. I. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. The Journal of Cell Biology, 96, 1662–1670.PubMed

34.

Cunha, G. R., Hayward, S. W., & Wang, Y. Z. (2002). Role of stroma in carcinogenesis of the prostate. Differentiation, 70, 473–485.PubMed

35.

Dawe, C. (1972). Epithelial–mesenchymal interactions in relation to the genesis of polyoma virus-induced tumors of mouse salivary gland. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 305–358). London: Academic.

36.

Tarin, D., Price, J. E., Kettlewell, M. G., et al. (1984). Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Research, 44, 3584–3592.PubMed

37.

Suzuki, M., Mose, E. S., Montel, V., et al. (2006). Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. The American Journal of Pathology, 169, 673–681.PubMed

38.

Paget, S. (1889). The distribution of secondary growths in cancer of the breast. The Lancet, i, 571–573.

39.

Hart, I. R., & Fidler, I. J. (1980). Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Research, 40, 2281–2287.PubMed

40.

Goodison, S., Kawai, K., Hihara, J., et al. (2003). Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clinical Cancer Research, 9, 3808–3814.PubMed

41.

Bresalier, R. S., Raper, S. E., Hujanen, E. S., et al. (1987). A new animal model for human colon cancer metastasis. International Journal of Cancer, 39, 625–630.

42.

Morikawa, K., Walker, S. M., Nakajima, M., et al. (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Research, 48, 6863–6871.PubMed

43.

Naito, S., von Eschenbach, A. C., Giavazzi, R., et al. (1986). Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Research, 46, 4109–4115.PubMed

44.

Stephenson, R. A., Dinney, C. P., Gohji, K., et al. (1992). Metastatic model for human prostate cancer using orthotopic implantation in nude mice. Journal of the National Cancer Institute, 84, 951–957.PubMed

45.

Montel, V., Mose, E. S., & Tarin, D. (2006). Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. International Journal of Cancer Journal International du Cancer, 119, 251–263.PubMed

46.

Bao, L., Pigott, R., Matsumura, Y., et al. (1993). Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation, 52, 239–246.PubMed

47.

Tarin, D., & Croft, C. B. (1970). Ultrastructural studies of wound healing in mouse skin. II. Dermo-epidermal interrelationships. Journal of Anatomy, 106, 79–91.PubMed

48.

Croft, C. B., & Tarin, D. (1970). Ultrastructural studies of wound healing in mouse skin. I. Epithelial behaviour. Journal of Anatomy, 106, 63–77.PubMed

49.

Cowell, T. (1972). Control of epithelial invasion by connective tissue during embedding of the mouse ovum. In D. Tarin (Ed.), Tissue interactions in carcinogenesis. London: Academic.

50.

Konijeti, R., Rajfer, J., & Askari, A. (2009). Placenta percreta and the urologist. Reviews in Urology, 11, 173–176.PubMed

51.

Tarin, D. (1968). Further electron microscopic studies on the mechanism of carcinogenesis: the specificity of the changes in carcinogen-treated mouse skin. International Journal of Cancer Journal International du Cancer, 3, 734–742.PubMed

52.

Tarin, D. (1969). Fine structure of murine mammary tumours: the relationship between epithelium and connective tissue in neoplasms induced by various agents. British Journal of Cancer, 23, 417–425.PubMed

53.

Tarin, D. (1972). Morphological studies on the mechanism of carcinogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 227–289). London: Academic.

54.

Brand, K. G., Buoen, L. C., Johnson, K. H., et al. (1975). Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review. Cancer Research, 35, 279–286.PubMed

55.

Buoen, L. C., Brand, I., & Brand, K. G. (1975). Foreign-body tumorigenesis: in vitro isolation and expansion of preneoplastic clonal cell populations. Journal of the National Cancer Institute, 55, 721–723.PubMed

56.

Karp, R. D., Johnson, K. H., Buoen, L. C., et al. (1973). Tumorigenesis by Millipore filters in mice: histology and ultrastructure of tissue reactions as related to pore size. Journal of the National Cancer Institute, 51, 1275–1285.PubMed

57.

Tarin, D. (2012). Clinical and biological implications of the tumor microenvironment. Cancer Microenvironment, 5, 95–112.

58.

Thiery, J. P. (2002). Epithelial–mesenchymal transitions in tumour progression. Nature Reviews. Cancer, 2, 442–454.PubMed

59.

Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial–mesenchymal transition. The Journal of Clinical Investigation, 119, 1420–1428.PubMed

60.

Mani, S. A., Guo, W., Liao, M. J., et al. (2008). The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704–715.PubMed

61.

Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9, 265–273.PubMed

62.

Thompson, E. W., Newgreen, D. F., & Tarin, D. (2005). Carcinoma invasion and metastasis: a role for epithelial–mesenchymal transition? Cancer Research, 65, 5991–5995. discussion 5995.PubMed

63.

Kang, Y., & Massague, J. (2004). Epithelial–mesenchymal transitions: twist in development and metastasis. Cell, 118, 277–279.PubMed

64.

Zeng, Q., Li, W., Lu, D., et al. (2012). CD146, an epithelial–mesenchymal transition inducer, is associated with triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 109, 1127–1132.PubMed

65.

Trimboli, A. J., Fukino, K., de Bruin, A., et al. (2008). Direct evidence for epithelial–mesenchymal transitions in breast cancer. Cancer Research, 68, 937–945.PubMed

66.

Thiery, J. P., Acloque, H., Huang, R. Y., et al. (2009). Epithelial–mesenchymal transitions in development and disease. Cell, 139, 871–890.PubMed

67.

Trelstad, R. L., Hay, E. D., & Revel, J. D. (1967). Cell contact during early morphogenesis in the chick embryo. Developmental Biology, 16, 78–106.PubMed

68.

Hay, E. (1968). Organization and fine structure of epithelium and mesenchyme in the developing chick embryo. In R. Fleischmajer & R. Billingham (Eds.), Epithelial mesenchymal interactions. Baltimore: Williams and Wilkins.

69.

Yang, J., & Weinberg, R. A. (2008). Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis. Developmental Cell, 14, 818–829.PubMed

70.

Tarin, D. (1971). Histological features of neural induction in Xenopus laevis. Journal of Embryology and Experimental Morphology, 26, 543–570.PubMed

71.

Tarin, D. (1971). Scanning electron microscopical studies of the embryonic surface during gastrulation and neurulation in Xenopus laevis. Journal of Anatomy, 109, 535–547.PubMed

72.

Tarin, D. (1972). Ultrastructural features of neural induction in Xenopus laevis. Journal of Anatomy, 111, 1–28.PubMed

73.

Tarin, D., & Sturdee, A. P. (1971). Early limb development of Xenopus laevis. Journal of Embryology and Experimental Morphology, 26, 169–179.PubMed

74.

Tarin, D., & Sturdee, A. P. (1974). Ultrastructural features of ectodermal–mesenchymal relationships in the developing limb of Xenopus laevis. Journal of Embryology and Experimental Morphology, 31, 287–303.PubMed

75.

Toivonen, S., Tarin, D., & Saxen, L. (1976). The transmission of morphogenetic signals from amphibian mesoderm to ectoderm in primary induction. Differentiation, 5, 49–55.PubMed

76.

Tarin, D. (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research, 65, 5996–6000.PubMed

77.

Gise, A., & Pu, W. T. (2012). Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circulation Research, 110, 1628–1645.

78.

Korsching, E., Packeisen, J., Liedtke, C., et al. (2005). The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? The Journal of Pathology, 206, 451–457.PubMed

79.

Gilbert, S. (2000). Developmental biology (6th edition ed). Sinauer Associates: Sunderland, MA, Chapter 14: Intermediate Mesoderm section Available from: http://www.ncbi.nlm.nih.gov/books/NBK10089/.

80.

Sucheston, M. E., & Cannon, M. S. (1968). Development of zonular patterns in the human adrenal gland. Journal of Morphology, 126, 477–491.PubMed

81.

Kempna, P., & Fluck, C. E. (2008). Adrenal gland development and defects. Best Practice & Research. Clinical Endocrinology & Metabolism, 22, 77–93.

82.

Satoh, M. (1991). Histogenesis and organogenesis of the gonad in human embryos. Journal of Anatomy, 177, 85–107.PubMed

83.

Kalluri, R., & Neilson, E. G. (2003). Epithelial–mesenchymal transition and its implications for fibrosis. The Journal of Clinical Investigation, 112, 1776–1784.PubMed

84.

Osterreicher, C. H., Penz-Osterreicher, M., Grivennikov, S. I., et al. (2011). Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proceedings of the National Academy of Sciences of the United States of America, 108, 308–313.PubMed

85.

Humphreys, B. D., Lin, S. L., Kobayashi, A., et al. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. The American Journal of Pathology, 176, 85–97.PubMed

86.

Tomaskovic-Crook, E., Thompson, E. W., & Thiery, J. P. (2009). Epithelial to mesenchymal transition and breast cancer. Breast Cancer Research, 11, 213.PubMed

87.

May, C. D., Sphyris, N., Evans, K. W., et al. (2011). Epithelial–mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Research, 13, 202.PubMed

88.

Yang, J., Mani, S. A., Donaher, J. L., et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927–939.PubMed

89.

Chui, M. H. (2012). Insights into cancer metastasis from a clinicopathologic perspective: epithelial mesenchymal transition is not a necessary step. International Journal of Cancer Journal International du Cancer. doi:10.1002/ijc.27745.PubMed

90.

Cardiff, R. D. (2010). The pathology of EMT in mouse mammary tumorigenesis. Journal of Mammary Gland Biology and Neoplasia, 15, 225–233.PubMed

91.

Hennessy, B. T., Gonzalez-Angulo, A. M., Stemke-Hale, K., et al. (2009). Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Research, 69, 4116–4124.PubMed

92.

Taube, J. H., Herschkowitz, J. I., Komurov, K., et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America, 107, 15449–15454.PubMed

93.

Brabletz, T. (2012). To differentiate or not—routes towards metastasis. Nature Reviews. Cancer, 12, 425–436.PubMed

94.

Brabletz, T., Jung, A., Reu, S., et al. (2001). Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proceedings of the National Academy of Sciences of the United States of America, 98, 10356–10361.PubMed

95.

Kubiak, R., & Szadowska, A. (1997). Invasive lobular carcinoma: correlations between morphological features, vimentin expression, oestrogen receptor status and prognosis. The Breast, 6, 89–96.

96.

Armstrong, A. J., Marengo, M. S., Oltean, S., et al. (2011). Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Molecular Cancer Research, 9, 997–1007.PubMed

97.

Powell, A. A., Talasaz, A. H., Zhang, H., et al. (2012). Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One, 7, e33788.PubMed

98.

Sun, Y., Campisi, J., Higano, C., et al. (2012).Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Medicine 18, 1359–1368.

99.

O’Mahony, F. C., Faratian, D., Varley, J., et al. (2012). The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PLoS One, 7, e31557.PubMed

100.

Leroy, P., & Mostov, K. E. (2007). Slug is required for cell survival during partial epithelial–mesenchymal transition of HGF-induced tubulogenesis. Molecular Biology of the Cell, 18, 1943–1952.PubMed

101.

Ledford, H. (2011). Cancer theory faces doubts. Nature, 472, 273.PubMed

102.

Hugo, H., Ackland, M. L., Blick, T., et al. (2007). Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. Journal of Cellular Physiology, 213, 374–383.PubMed

103.

Christiansen, J. J., & Rajasekaran, A. K. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research, 66, 8319–8326.PubMed

104.

Zhou, H., Wu, S., Joo, J. Y., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381–384.PubMed

105.

Wilmut, I., Schnieke, A. E., McWhir, J., et al. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature, 385, 810–813.PubMed

106.

Chaffer, C. L., Thompson, E. W., & Williams, E. D. (2007). Mesenchymal to epithelial transition in development and disease. Cells, Tissues, Organs, 185, 7–19.PubMed

107.

Tarin, D. (1967). Sequential electron microscopical study of experimental mouse skin carcinogenesis. International Journal of Cancer, 2, 195–211.

108.

Tarin, D. (1976). Cellular interactions in neoplasia. In L. Weiss (Ed.), Fundamental aspects of metastasis (pp. 151–187). Amsterdam: North Holland Publishing Co.

109.

Sugino, T., Gorham, H., Yoshida, K., et al. (1996). Progressive loss of CD44 gene expression in invasive bladder cancer. The American Journal of Pathology, 149, 873–882.PubMed

110.

Viadana, E., Bross, I. D., & Pickren, J. W. (1973). An autopsy study of some routes of dissemination of cancer of the breast. British Journal of Cancer, 27, 336–340.PubMed

111.

Noltenius, C., & Noltenius, H. (1985). Dormant tumor cells in liver and brain. An autopsy study on metastasizing tumors. Pathology Research and Practice, 179, 504–511.

112.

Suzuki, M., Mose, E., Galloy, C., et al. (2007). Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. The American Journal of Pathology, 171, 682–692.PubMed

113.

Urquidi, V., Sloan, D., Kawai, K., et al. (2002). Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clinical Cancer Research, 8, 61–74.PubMed

114.

Agrawal, D., Chen, T., Irby, R., et al. (2002). Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. Journal of the National Cancer Institute, 94, 513–521.PubMed

115.

Ang, C., Chambers, A. F., Tuck, A. B., et al. (2005). Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder. BJU International, 96, 803–805.PubMed

116.

Donati, V., Boldrini, L., Dell’Omodarme, M., et al. (2005). Osteopontin expression and prognostic significance in non-small cell lung cancer. Clinical Cancer Research, 11, 6459–6465.PubMed

117.

Jang, T., Savarese, T., Low, H. P., et al. (2006). Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. The American Journal of Pathology, 168, 1676–1685.PubMed

118.

Matusan, K., Dordevic, G., Stipic, D., et al. (2006). Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma. Journal of Surgical Oncology, 94, 325–331.PubMed

119.

Roland, P. Y., Kelly, F. J., Kulwicki, C. Y., et al. (2004). The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecologic Oncology, 93, 125–130.PubMed

120.

Wai, P. Y., & Kuo, P. C. (2004). The role of osteopontin in tumor metastasis. The Journal of Surgical Research, 121, 228–241.PubMed

121.

Feng, W., McCabe, N. P., Mahabeleshwar, G. H., et al. (2008). The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. The Journal of Cell Biology, 183, 1145–1157.PubMed

122.

Kelly, P. N., Dakic, A., Adams, J. M., et al. (2007). Tumor growth need not be driven by rare cancer stem cells. Science, 317, 337.PubMed

123.

Price, J. E., Syms, A. J., Wallace, J. S., et al. (1986). Cellular immortality, clonogenicity, tumorigenicity and the metastatic phenotype. European Journal of Cancer & Clinical Oncology, 22, 349–355.

124.

Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews. Cancer, 8, 755–768.PubMed

125.

Wang, G. X., Zhan, Y. A., Hu, H. L., et al. (2012). Mesenchymal stem cells modified to express interferon-beta inhibit the growth of prostate cancer in a mouse model. The Journal of International Medical Research, 40, 317–327.PubMed

126.

Schrodinger, E. (1944). What is life (p. 194). Cambridge, UK: Cambridge University Press.

Titel: Role of the host stroma in cancer and its therapeutic significance
verfasst von: David Tarin
Publikationsdatum: 01.12.2013
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 3-4/2013
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-013-9438-4

Springer Medizin

Role of the host stroma in cancer and its therapeutic significance

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3-4/2013

Preface

Functions, divergence and clinical value of TAp73 isoforms in cancer

Update on clinical and mechanistic aspects of paraneoplastic syndromes

Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?

Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells

The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie